Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2020 Issue has been successfully launched on 1 November 2020

Abstract

THERAPEUTIC APPLICATION BROMFENAC, MOXIFLOXACIN AND MOXI-DEXAMETHASONE IN EYE DISORDERS

Parvathi M. L., Rachita Kurmi and Silpa T. S.

ABSTRACT

The purpose of this pooled analysis is to investigate the safety and efficacy of once daily Bromfenac for ocular inflammation and pain among patients after cataract extraction (CE). Bromfenac, a promising ophthalmic non-steroidal anti-inflammatory drug, has been shown to be a safe and effective treatment for postoperative pain and inflammation in subjects undergoing CE. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COXs so as to inhibit post- operative pain and inflammation. It is becoming prevalent to begin NSAIDs dosing anywhere from 1–2 days before surgery to reduce postoperative inflammation and pain.

Keywords: .


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More